In the evolving landscape of biologics, monoclonal antibodies (mAbs) have emerged as one of the most powerful therapeutic modalities, offering high specificity, prolonged half-life, and unparalleled versatility in disease targeting. Yet, despiteRead More…
Artificial intelligence (AI) is rapidly transforming the landscape of therapeutic antibody discovery and engineering. As the biopharmaceutical industry continues to demand faster, more precise, and cost-effective development pipelines, AI-driven solutions have emergedRead More…
Antibody-based therapeutics have emerged as one of the most successful classes of biologics for cancer treatment. Yet, the development of these complex biomolecules remains a formidable task, requiring the integration of structuralRead More…
The Limitations of Traditional Antibody Discovery and AI’s Disruptive Potential For decades, antibody drug development has relied on labor-intensive methods such as hybridoma technology and phage display—processes that often requiring 10-15 yearsRead More…
Introduction: The Convergence of AI and Medicine In recent years, the intersection of artificial intelligence (AI) and healthcare has emerged as one of the most promising frontiers. Among the myriad applications, theRead More…
Artificial intelligence (AI) has become a critical tool in modern drug development, particularly in the fields of drug repurposing and repositioning. AI’s capacity to analyze vast and complex biological, chemical, and clinicalRead More…
Introduction Drug discovery is a long, costly, and high-risk process. Developing an innovative drug, from initial research to market launch, typically spans 10 to 15 years, with an average cost of $1Read More…
Introduction The pharmaceutical industry is facing an unprecedented challenge in drug discovery, with the cost of developing new drugs soaring to an estimated $6.16 billion in 2023—more than double the adjusted costRead More…
Introduction The rapid evolution of artificial intelligence (AI) has revolutionized multiple sectors, including the pharmaceutical industry. A review article titled “The Applications and Advances of Artificial Intelligence in Drug Regulation: A GlobalRead More…
The 2024 Nobel Prizes brought artificial intelligence (AI) to the forefront, with groundbreaking work recognized in physics and chemistry. On October 8, the Nobel Prize in Physics was awarded to two pioneersRead More…